SICHUAN DEEBIO PHARMACEUTICAL CO., LTD

Year of Establishment: 1994

Total Assets(USD): 45,000,000 To 49,999,999

Total Number of Staff: 400 to 449

Main Competitive Advantages: Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: 1. The first API manufacturer of enzymes which got the EU-GMP certification for pancreatin, pepsin, trypsin-chymotrypsin, alpha-chymotrypsin and trypsin in China; 2. The first company to produce trypsin-chymotrypsin in China; 3. Pancreatin production ability is the No. 1 all over the world; 4. No. 1 and only one enzyme manufacturer listed on stock market in China.

Patents and Copyrights: 1. The first batch of Academicians' expert workstations in Deyang City; 2. Animal by-products extraction technology research center in Sichuan Province; 3. Approved to establish postdoctoral innovation and practice base by Sichuan Province Human Resources and Social Security Department; 4. Obtain six patents authorization: four are the inventory patents and two are Utility Model Patents; 5. Successively undertake country,province,city's sixty-two major science research projects and technology revolution projects; 6. Many projects passed the Province's technology result's identification, attain domestic lead level, reach the international leading level.